Search
Displaying 1071–1080 of 1142 results
-
Inspired by Progress in Usher Syndrome Research
Research NewsMark Pennesi, M.D., Ph.D., a Foundation-funded clinical researcher at the Casey Eye Institute, discusses the first human study of gene therapy for Usher syndrome type 1B.
-
How Evolution is Leading to Gene Therapies for More Retinal Diseases
Research NewsAn innovative genetic-engineering approach called “directed evolution” to find optimal gene-delivery systems based on adeno-associated viruses (AAVs).
-
Despite Blindness, the Peaches are Sweet in Paran
Research NewsThe story of vision loss in a Peruvian village
-
Lighting a Candle: The Author of a New Memoir Shares the Highs and Lows of Vision Loss
Beacon StoriesNicole Simpson, author of “Now I See You,” shares her experience with retinitis pigmentosa.
-
VISIONS 2014 — My Retina Tracker: Track Your Vision and Drive the Research
Research NewsThe powerful and secure system enables patients to keep track of their clinical care and vision changes. At the same time, it enables scientists to search the “de-identified” (i.e., anonymous) patient information to study conditions and identify targets for treatments, preventions and cures.
-
VISIONS 2014 — The Multi-Talented Dr. Shannon Boye
Research NewsDr. Boye and her research team received a $900,000 grant for a gene therapy project targeting Leber congenital amaurosis.
-
ARVO 2014: European Collaboration Developing Cross-Cutting, Vision-Saving Therapies
Research NewsSimply put, they’re creating therapies that can save vision in as many people as possible, independent of the genetic cause of disease.
-
Flight4Sight: A Man with Usher Syndrome Travels Around the Globe
Beacon StoriesThere’s nothing like a sense of urgency to turn what seems like a crazy idea into reality.
-
Total Blindness and Non-24 Sleep Disorder
Research NewsNon-24 is a very rare condition affecting many (but not all) people who are totally blind and have absolutely no light perception. Their circadian clocks become out of sync as a result.
-
UCI Stem-Cell Pioneer Poised to Launch Clinical Trial for RP Patients
Research NewsDr. Henry Klassen’s progenitor-based therapy has the potential to rescue a variety of retinal cells — including rods, cones, retinal pigment epithelium and ganglion cells — and, therefore, may save vision in people with a wide range of conditions.
